Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use APIDRA safely and effectively. See full prescribing information for APIDRA. APIDRA® (insulin glulisine) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2004
Medication labelWhy this: Advisory · dailymed-prescription
APIDRA is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus.
- generic_name
- insulin glulisine
- product_names
- insulin glulisine
- ndc
- 0088-2500, 0088-2502, 0088-2500-33, 0088-2500-34, 0088-2502-00, 0088-2502-05, 0088-2502-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en